Skip to main content

Table 2 Univariate and multivariate analysis of overall survival in gastric cancer (GC) patients who underwent gastrectomy in the training cohort

From: A novel immunohistochemical score predicts the postoperative prognosis of gastric cancer patients

 

Univariate analysis

Multivariate analysis

P

HR

95% confidence interval

P

HR

95% confidence interval

Gender

 Male/female

0.921

1.020

0.692–1.504

   

Age

 > 60 years/ ≤ 60 years

0.181

0.817

0.608–1.099

   

ASA

 II/I

0.714

0.920

0.587–1.440

   

ECOG PS

 1/0

0.984

1.004

0.706–1.427

   

TNM stage

< 0.001

1.711

1.490–1.965

< 0.001

1.584

1.365–1.837

Tumor size

0.002

1.594

1.182–2.149

0.119

1.283

0.938–1.755

 > 5.0 cm/ ≤ 5.0 cm

      

Vascular invasion

0.427

1.131

0.835–1.531

   

 Yes/No

      

P53

< 0.001

2.298

1.682–3.140

0.005

1.862

1.205–2.880

 ± 

      

Ki-67

 ≥ / < 

< 0.001

2.614

1.923–3.555

0.027

1.606

1.055–2.444

MSI status

 MSI-high/MSS or MSI-low

 < 0.001

2.710

1.880–3.907

< 0.001

2.771

1.864–4.121

  1. TNM stages are according to AJCC 8th edition
  2. ASA American Society of Anesthesiologists, ECOG Eastern Cooperative Oncology Group, PS performance status, MSI microsatellite instability, MSS microsatellite stable, HR hazard ratio